Byonyks on the Move: X-2 and X-3 APD Devices in Development

The pipeline devices will make ultrapure, non-inflammatory, and biocompatible dialysate on-demand to reduce medical waste, reduce the risk of peritonitis and enhance patient quality of life.

Read the full article » | Posted 07-16-2026

Related Articles

• Proof of Concept for Silicon Nanopore Membrane Implantable HD Posted 10-05-2026
• AWAK PD To Go Posted 10-05-2026
• The Lancet Digital Health published results of Humacyte’s Phase III clinical trial of its V007 acellular tissue engineered vessel (ATEV) HD access Posted 09-18-2026
• Humacyte, Inc. announced Robert J. Kossman, MD, FACP, FASN and Prabir Roy-Chaudhury, MD, PhD, FASN have joined the company as advisors. Posted 08-21-2026